CLOV vs CI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CLOV

45.8
AI Score
VS
CI Wins

CI

51.8
AI Score

Investment Advisor Scores

CLOV

46score
Recommendation
HOLD

CI

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV CI Winner
Forward P/E 37.7358 8.7413 CI
PEG Ratio 0 0.8058 Tie
Revenue Growth 53.1% 5.6% CLOV
Earnings Growth 0.0% -21.6% CLOV
Tradestie Score 45.8/100 51.8/100 CI
Profit Margin 0.4% 2.1% CI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CLOV 1M: +3.3% · 3M: +10.7% CI 1M: +6.7% · 3M: +8.4%

Current Technical Phase

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 60

RSI (14): 59.7 · Price: $4.97

CI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 56

RSI (14): 55.6 · Price: $301.45

Fundamentals Snapshot

Metric CLOV CI
Market Cap — —
Forward P/E 27.6 9.0
Trailing P/E 493.0 13.4
Revenue (TTM) — —
Revenue Growth 0.5% 0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% 0.0%
EPS 0.01 22.68
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, CI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.